Clinical Trial

Cardiac Anodal Biphasic Pacing

Study acronym: ABP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this study is to test a new pacing method called anodal biphasic pacing (ABP) to determine if this pacing works as well-or better-than current pacing methods. This new method may improve how the heart works and reduce some of the problems caused by regular pacing. Current implantable pacemakers use a monophasic cathodal waveform to stimulate the heart. Monophasic cathodal pacing (MCP) waveforms slow conduction, impair contractility, cause inflammation, increase risk of atrial fibrillation, heart failure, and mortality. Anodal biphasic pacing (ABP) is an alternative waveform that can stimulate the heart. ABP preconditions the heart and then initiates cardiac contraction. ABP may address the limitations of MCP.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-07 -> 2027-12 2026-07-29
minor Completion pushed: 2027-07 -> 2027-12 2026-07-29
Trial Details
NCT Number NCT07173777
Lead Sponsor Boston Medical Center
Collaborators: Rocky Mountain Biphasic
Conditions Cardiac Pacing
Enrollment 108 participants
Start Date 2026-09
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-28